ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: New DRCCA Recruits: Cullen Will Be Greenwalds’s Deputy, Frelick To Become CCOP Project Officer

April 2, 1982

Clinical Education Guidelines Proposed

April 4, 1975

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

October 21, 1988

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996